Basit öğe kaydını göster

dc.contributor.authorTunçel Ö.K.
dc.contributor.authorSarısoy G.
dc.contributor.authorBilgici B.
dc.contributor.authorPazvantoğlu O.
dc.contributor.authorÇetin E.
dc.contributor.authorTunçel E.K.
dc.date.accessioned2020-06-21T09:43:45Z
dc.date.available2020-06-21T09:43:45Z
dc.date.issued2018
dc.identifier.issn0803-9488
dc.identifier.urihttps://doi.org/10.1080/08039488.2017.1402953
dc.identifier.urihttps://hdl.handle.net/20.500.12712/5377
dc.descriptionPubMed: 29132244en_US
dc.description.abstractPurpose: Obesity and metabolic syndrome (MeS) are more frequently observed in bipolar patients than the general population. This may result from the differences of adipocytokines and ghrelin levels in bipolar disorder. Material and methods: We evaluated the leptin, adiponectin, resistin and ghrelin levels in bipolar patients (n = 30) in manic episode and in a control group (n = 30). After treatment, the same patients were evaluated again during the euthymic episode. We also measured the insulin, glucose, insulin resistance (HOMA), trygliceride (TG), total cholesterol (TCHOL), high density lipoprotein cholesterol (HDL) and low density lipoprotein cholesterol (LDL) in relation to the (MeS). Results: When controlling for age, BMI and glucose, leptin levels were higher in the bipolar disorder manic episode group (BD-ME) and bipolar euthymic episode group (BD-EE) than the control group; resistin levels were higher in the BD-ME compared to the control group and it had a positive correlation with Young Mania Rating Scale (YMRS). After treatment, ghrelin levels were higher in the BD-EE compared to the BD-ME group. There was no difference among the groups with respect to adiponectin. Conclusions: The present results point that high leptin, resistin and ghrelin levels may be involved in the early pathophysiological process which can lead to later obesity and MeS in patients with bipolar disorder. © 2017 The Nordic Psychiatric Association.en_US
dc.description.sponsorshipThis study was conducted in Ondokuz Mayıs University, Psychiatry Clinic on 18–65 years old bipolar patients (n = 30) and a control group (n = 30). Both groups were sex and age matched. All subjects were evaluated by two psychiatrists. Bipolar disorder was diagnosed with clinical examination using The Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Same patients diagnosed in bipolar 1 disorder were studied twice during manic and euthymic episode. Manic episode was considered euthymic if they had a Young Mania Rating Scale (YMRS) score less than five for two months following their treatment [22]. All patients were treated in the manic episode in the hospital and they were followed as outpatient during the euthymic episode. Comorbidity was excluded using Structured Clinical Interview for DSM-IV axis I disorders (SCID-I) [23] and Structured Clinical Interview for DSM-III-R personalitydisorder (SCID-II) [24] in both patients and control groups. Potential participants with comorbid conditions were excluded. The control group consisted of subjects who had never suffered from a psychiatric disease and who had no immediate family member with a history of a major psychiatric disorder. All subjects had a body mass index of ?25 kg/m2 and were nonsmokers. They also had no drug addiction or chronic disease (infection, inflammatory disease, diabetes, hypertension, cancer, etc.). This study was approved by Ondokuz Mayıs University, Medical Research Ethical Committee (No: 2012/72 Issue: B.30.2.ODM.0.20.08/117). All procedures were in accordance with the World Medical Association Declaration of Helsinki. All subjects gave written informed consent.en_US
dc.language.isoengen_US
dc.publisherTaylor and Francis Ltden_US
dc.relation.isversionof10.1080/08039488.2017.1402953en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAdiponectinen_US
dc.subjectbipolar disorderen_US
dc.subjectghrelinen_US
dc.subjectleptinen_US
dc.subjectresistinen_US
dc.titleAdipocytokines and ghrelin level of bipolar patients from manic episode to euthymic episodeen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume72en_US
dc.identifier.issue2en_US
dc.identifier.startpage150en_US
dc.identifier.endpage156en_US
dc.relation.journalNordic Journal of Psychiatryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster